We also tested the efficacy of PF-06747143 in leukemia growth in a PDX model reconstituted with P15 AML patient primary cells characterized by high CXCR4 expression (P15CXCR4-high) (Supplemental Table 1). Here, CXCR4 is linked to leukemia.